In many patients with allergies, intradermal challenge with a specific antigen or anti-IgE induces an immediate wheal and flare reaction that is followed 4–8 h later by a period of persistent swelling and leukocyte infiltration termed the late-phase cutaneous reaction [18–19]. The gene discussed is IGHE; the disease is allergic disease.